Advertisement

Loss of the selective autophagy receptor p62 impairs murine myeloid leukemia progression and mitophagy

The Duy Nguyen, Shabnam Shaid, Olesya Vakhrusheva, Sebastian E. Koschade, Kevin Klann, Marlyn Thölken, Fatima Baker, Jing Zhang, Thomas Oellerich, Duran Sürün, Anja Derlet, Isabella Haberbosch, Stefan Eimer, Heinz D. Osiewacz, Christian Behrends, Christian Münch, Ivan Dikic and Christian H. Brandts

Article Information

Citation 
vol. 133 no. 2 168-179
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted February 12, 2018
  • Accepted November 26, 2018
  • Published online January 10, 2019.

Article Versions


Contributors 
  • The Duy Nguyen, 1Department of Medicine, Hematology/Oncology, Goethe University, Frankfurt, Germany; 2German Cancer Consortium and German Cancer Research Center, Heidelberg, Germany;
  • Shabnam Shaid, 1Department of Medicine, Hematology/Oncology, Goethe University, Frankfurt, Germany; 2German Cancer Consortium and German Cancer Research Center, Heidelberg, Germany;
  • Olesya Vakhrusheva, 1Department of Medicine, Hematology/Oncology, Goethe University, Frankfurt, Germany;
  • Sebastian E. Koschade, 1Department of Medicine, Hematology/Oncology, Goethe University, Frankfurt, Germany;
  • Kevin Klann, 3Institute of Biochemistry II, Goethe University, Frankfurt, Germany;
  • Marlyn Thölken, 1Department of Medicine, Hematology/Oncology, Goethe University, Frankfurt, Germany;
  • Fatima Baker, 1Department of Medicine, Hematology/Oncology, Goethe University, Frankfurt, Germany; 2German Cancer Consortium and German Cancer Research Center, Heidelberg, Germany;
  • Jing Zhang, 1Department of Medicine, Hematology/Oncology, Goethe University, Frankfurt, Germany;
  • Thomas Oellerich, 1Department of Medicine, Hematology/Oncology, Goethe University, Frankfurt, Germany; 2German Cancer Consortium and German Cancer Research Center, Heidelberg, Germany; 4Cambridge University Department of Hematology, Cambridge Institute of Medical Research, Cambridge, United Kingdom;
  • Duran Sürün, 1Department of Medicine, Hematology/Oncology, Goethe University, Frankfurt, Germany;
  • Anja Derlet, 5Institute for Cardiovascular Regeneration, Goethe University, Frankfurt, Germany;
  • Isabella Haberbosch, 6Department of Hematology, Oncology, and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany;
  • Stefan Eimer, 7Institute of Cell Biology & Neuroscience and
  • Heinz D. Osiewacz, 8Institute of Molecular Biosciences and Cluster of Excellence Macromolecular Complexes, Goethe University, Frankfurt, Germany;
  • Christian Behrends, 3Institute of Biochemistry II, Goethe University, Frankfurt, Germany; 9Munich Cluster for Systems Neurology, Ludwig Maximilian University Munich, Munich, Germany; and
  • Christian Münch, 3Institute of Biochemistry II, Goethe University, Frankfurt, Germany;
  • Ivan Dikic, 2German Cancer Consortium and German Cancer Research Center, Heidelberg, Germany; 3Institute of Biochemistry II, Goethe University, Frankfurt, Germany; 10Buchmann Institute for Molecular Life Sciences and
  • Christian H. Brandts, 1Department of Medicine, Hematology/Oncology, Goethe University, Frankfurt, Germany; 2German Cancer Consortium and German Cancer Research Center, Heidelberg, Germany; 11University Cancer Center Frankfurt, Goethe University, Frankfurt, Germany

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output